Loading posts...
Clinical Trials Haulted for Promising Drug in the Treatment of Autism
View

Clinical Trials Haulted for Promising Drug in the Treatment of Autism

 Seaside Therapeutics' clinical trials for the drug Arbaclofen placarbil have recently been shutdown due to funding issues. On May 15, 2013, the sponsor of Arbaclofen sent an announcement to the clinics involved in the administration of the drug stating “We re...